Forte Biosciences, Inc. (FBRX)

CIK 1419041 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Forte Biosciences, Inc..

Recent SEC filings

FiledFormAccession number
Sep 8, 202615-12G0001140361-26-035937
Sep 8, 2026SCHEDULE 13G/A0001623632-26-001385
Sep 8, 202615-12G0001140361-26-035938
Sep 8, 202615-12G0001140361-26-035936
Sep 1, 2026EFFECT9999999995-26-002846
Sep 1, 2026EFFECT9999999995-26-002847
Sep 1, 2026EFFECT9999999995-26-002848
Sep 1, 2026EFFECT9999999995-26-002850
Sep 1, 2026EFFECT9999999995-26-002844
Sep 1, 2026EFFECT9999999995-26-002843
Aug 27, 2026POS AM0001140361-26-034721
Aug 27, 202625-NSE0001354457-26-000824
Aug 27, 202640001242116-26-000001
Aug 27, 202640001202335-26-000003
Aug 27, 202640001269341-26-000003
Aug 27, 2026POS AM0001140361-26-034720
Aug 27, 2026POS AM0001140361-26-034719
Aug 27, 2026S-8 POS0001140361-26-034711
Aug 27, 2026SC 14D9/A0001140361-26-034553
Aug 27, 2026S-8 POS0001140361-26-034712
Aug 27, 2026S-8 POS0001140361-26-034710
Aug 27, 2026S-8 POS0001140361-26-034709
Aug 27, 2026S-8 POS0001140361-26-034713
Aug 27, 202640001339375-26-000011
Aug 27, 2026S-8 POS0001140361-26-034703